Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
LULUTOX Detox Tea in Consumer Coverage as Website Update Introduces More Transparency in Herbal Digestive Supplement Information
Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support
Profound Medical Corp. Announces Upsize of Private Placement
REDWOOD CITY, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company...
NEW YORK, March 30, 2021 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID) (“Ovid”), a biopharmaceutical company committed to developing...
SAN CARLOS, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a leader in the development of comprehensive solutions for...
NEW YORK and LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA, LSE: TILS) (“Tiziana” or...
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
This is a press release by Kiadis Pharma N.V. (“Kiadis”) in connection with the public offer by Sanofi Foreign Participations...
NEW YORK and LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences. (NASDAQ: TLSA; LSE: TILS), a biotechnology company...
Maylen Farma to Market Treatment in 20 Countries across Europe, Central Asia and the Middle EastTORONTO, March 30, 2021 (GLOBE...
COPENHAGEN, Denmark, March 30, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the...
CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing...
WILMETTE, Ill., March 30, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on...
Exebacase Phase 3 DISRUPT study enrollment ongoing in patients with Staph aureus bloodstream infections; results from interim futility analysis anticipated...
Press release Ecully, 29 March 2021 – 6 p.m. Continued international development Workshop in Thailand dedicated to Spineway implants and...
Wambach joins a growing team assembled to increase awareness regarding the unmet medical need for a treatment for brain injuries...
COPENHAGEN, Denmark, March 30, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative...
Silence Therapeutics Reports Full-year 2020 ResultsAdvancing clinical programmes; On-track for three phase 1 data readouts in 2021 30 March 2021...
Phase 1a data update from clinical ACTengine® programs demonstrated first anti-tumor activity at early phases of dose escalation in heavily...
MIAMI, March 30, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing...
SAN FRANCISCO, March 30, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (“Augmedix”), a leading provider of remote medical documentation and live...
Tests designed to detect active COVID-19 infection with a simple, easy-to-use workflowBETHLEHEM, Pa., March 30, 2021 (GLOBE NEWSWIRE) -- OraSure...
